Castle Biosciences to Release Third Quarter 2021 Financial Results and Host Conference Call on Monday, Nov. 8, 2021
Company management will host a conference call and webcast to discuss its financial results at
Conference Call and Webcast Details
A live webcast of the conference call can be accessed here: https://www.incommglobalevents.com/viewer/14309/castle-biosciences-q3-2021-earnings-call/ or via the webcast link on the Investor Relations page of the Company’s website, https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. An archive of the webcast will be available on the Company’s website until
To access the live conference call via phone, please dial 844 200 6205 from
There will be a brief Question & Answer session following management commentary.
About
Castle also has active research and development programs for tests in other dermatologic diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate to severe psoriasis, atopic dermatitis and related conditions.
For more information, visit www.CastleBiosciences.com.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, myPath Melanoma, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of
View source version on businesswire.com: https://www.businesswire.com/news/home/20211025005091/en/
Investor Contact:
832-835-5158
czuckero@castlebiosciences.com
Media Contact:
amarshall@castlebiosciences.com
Source: